Growth Opportunity NellOne Therapeutics is a startup biotech focused on ARDS and related respiratory conditions with NSF and private funding, presenting an opportunity to engage on collaboration, pilot studies, or early-access programs for novel therapeutics or platform technologies tailored to critical care and hospital systems.

Strategic Partners Recent investment by Three Roots Capital and a track record of investor activity suggest openness to strategic partnerships, co-development, or licensing discussions that could accelerate clinical programs or expand commercialization reach in niche respiratory disease markets.

Healthcare Impact Their mission to improve quality of life and reduce healthcare burden from CARDS aligns with hospitals and payer interests; target opportunities include integrated care pathways, outcomes-based pricing discussions, and partnerships with health systems for real-world data generation.

Geographic Footprint With a base in Knoxville and a planned Fairview New Jersey location indicates a U.S. presence strategy; sales outreach can leverage regional hospital networks, contract opportunities, and local biotech ecosystem partnerships to establish regional pilots.

Funding & Scale Sub-$1M revenue and $1.7M funding signal early-stage needs; potential sales angles include laboratory services, cloud/agile data infrastructure, digital tools for clinical development, and collaboration on grant-enabled research support or pilot production facilities.